PHC Holdings Corporation

About Us
Group Companies
Products & Services
CSR
Investor Relations

About Us

Corporate Overview History Our Culture Leadership

Group Companies

Ascensia Epredia PHCbi Medicom LSI Medience

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

CSR

CORPORATE INTEGRITY

PEOPLE INSIGHTS

ENVIRONMENTAL SUSTAINABILITY

Environmental Activities

SOCIAL RESPONSIBILITY

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

IR LIBRARY

STOCK INFORMATION

IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom Careers Contact

JP

Other PHC Group Websites

Other PHC Group Websites

Newsroom Careers Contact JP

News

2022

Select year
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015

PHC Holdings Corporation

Group Companies

May.25IR: Notice regarding the Early Retirement Program at PHC Holdings Corporation and the consolidated subsidiaries
May.25News: Announcement of Changes to Board of Directors at PHC Holdings Corporation Effective June 29 and July 1
May.12IR: PHC Holdings Corporation Announces FY21 Full-Year Results and FY22 Forecast
Apr.28News: PHC Holdings Corporation Appoints Shoji Miyazaki as Chief Executive Officer
Apr.22News: Resignation of Independent External Director of PHC Holdings Corporation
Apr.4News: Resignation of Independent External Director of PHC Holdings Corporation

Jan.19News: Changes in Corporate Officer Areas of Responsibility at PHC Holdings Corporation Effective January 19, 2022

May.25PHCCorporate: Announcement of New Appointment of a Director at PHC Corporation Effective on June 27, 2022
May.2AscensiaProducts: Ascensia Diabetes Care Presents New Research Showing that People Using the CONTOUR® Blood Glucose Monitoring System and App Experience Fewer Out-of-Target Blood Glucose levels
Apr.18PHC IVDProducts: PHC Receives First EU-MDR Certification, Delivers Motorized Drug Injection Device Enabling More Efficient Patient-Friendly Treatment of Arthritis and Other Inflammatory Conditions
Apr.4AscensiaProducts: Ascensia Diabetes Care Launches the 6 Month Eversense® E3 Continuous Glucose Monitoring System in the U.S. with the New Eversense Pass Savings Program
Mar.1AscensiaProducts: Ascensia Diabetes Care Launches the Eversense® Now Remote Monitoring App for Android Users in Europe
Feb.14AscensiaProducts: Ascensia Diabetes Care Announces FDA Approval of the Eversense E3 Continuous Glucose Monitoring System for Use for Up to 6 Months
Feb.14AscensiaCorporate: Ascensia Diabetes Care Proudly Supports Spare a Rose Campaign for Fifth Consecutive Year